98 related articles for article (PubMed ID: 10349782)
21. [Selection of resistance mutants and bacteriostatic and bactericidal activity of meropenem and imipenem against Acinetobacter spp].
Villar HE; Laurino G; Arena MF; Hoffman M
Enferm Infecc Microbiol Clin; 1997 Mar; 15(3):140-3. PubMed ID: 9235053
[TBL] [Abstract][Full Text] [Related]
22. Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem.
Pachón-Ibáñez ME; Jiménez-Mejías ME; Pichardo C; Llanos AC; Pachón J
Antimicrob Agents Chemother; 2004 Nov; 48(11):4479-81. PubMed ID: 15504889
[TBL] [Abstract][Full Text] [Related]
23. In vitro effect of subinhibitory concentrations of ceftazidime and meropenem on the serum sensitivity of Pseudomonas aeruginosa strains.
Drenjancević D; Vranes J; Bedenić B; Sakić-Zdravcević K
Coll Antropol; 2007 Mar; 31(1):221-5. PubMed ID: 17598405
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
Song JY; Cheong HJ; Lee J; Sung AK; Kim WJ
Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761
[TBL] [Abstract][Full Text] [Related]
25. Effect of meropenem on the vascular permeability factor produced by Acinetobacter baumannii.
Hostacká A
Arzneimittelforschung; 2000 Apr; 50(4):387-90. PubMed ID: 10800638
[TBL] [Abstract][Full Text] [Related]
26. In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates.
Tan TY; Ng LS; Tan E; Huang G
J Antimicrob Chemother; 2007 Aug; 60(2):421-3. PubMed ID: 17540671
[TBL] [Abstract][Full Text] [Related]
27. The comparative inhibitory and bactericidal activities of meropenem and imipenem against Acinetobacter spp. and Enterobacteriaceae resistant to second generation cephalosporins.
MacGowan AP; Bowker KE; Bedford KA; Holt HA; Reeves DS; Hedges A
J Antimicrob Chemother; 1995 Feb; 35(2):333-7. PubMed ID: 7759397
[TBL] [Abstract][Full Text] [Related]
28. Discordance of meropenem versus imipenem activity against Acinetobacter baumannii.
Ikonomidis A; Pournaras S; Maniatis AN; Legakis NJ; Tsakris A
Int J Antimicrob Agents; 2006 Oct; 28(4):376-7. PubMed ID: 16949256
[No Abstract] [Full Text] [Related]
29. [Prevalence of Acinetobacter baumannii and Pseudomonas aeruginosa isolates resistant to imipenem by production of metallo-beta-lactamase].
Ait El Kadi M; Aghrouch M; Seffar M; El harti J; Bouklouze A; Cherrah Y; Souly K; Zouhdi M
Med Mal Infect; 2006 Jul; 36(7):386-9. PubMed ID: 16842953
[TBL] [Abstract][Full Text] [Related]
30. Imipenem resistance among Acinetobacter baumannii: association with reduced expression of a 33-36 kDa outer membrane protein.
Clark RB
J Antimicrob Chemother; 1996 Aug; 38(2):245-51. PubMed ID: 8877538
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia.
Bernabeu-Wittel M; Pichardo C; García-Curiel A; Pachón-Ibáñez ME; Ibáñez-Martínez J; Jiménez-Mejías ME; Pachón J
Clin Microbiol Infect; 2005 Apr; 11(4):319-25. PubMed ID: 15760430
[TBL] [Abstract][Full Text] [Related]
32. [Interaction of bactericidal serum effect and antibiotics in subminimal inhibitory concentrations on E. coli strains].
Gillissen G; Schumacher M; Breuer-Werle M
Pathol Biol (Paris); 1990 May; 38(5):436-40. PubMed ID: 2195453
[TBL] [Abstract][Full Text] [Related]
33. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit.
Pournaras S; Markogiannakis A; Ikonomidis A; Kondyli L; Bethimouti K; Maniatis AN; Legakis NJ; Tsakris A
J Antimicrob Chemother; 2006 Mar; 57(3):557-61. PubMed ID: 16431857
[TBL] [Abstract][Full Text] [Related]
34. [Effect of tobramycin on characteristics of strains of Acinetobacter species].
Hostacká A
Ceska Slov Farm; 2003 Jul; 52(4):193-7. PubMed ID: 12924072
[TBL] [Abstract][Full Text] [Related]
35. Synergic in-vitro activity of imipenem and sulbactam against Acinetobacter baumannii.
Choi JY; Park YS; Cho CH; Park YS; Shin SY; Song YG; Yong D; Lee K; Kim JM
Clin Microbiol Infect; 2004 Dec; 10(12):1098-101. PubMed ID: 15606639
[TBL] [Abstract][Full Text] [Related]
36. In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals.
Fraenkel CJ; Ullberg M; Bernander S; Ericson E; Larsson P; Rydberg J; Törnqvist E; Melhus A
Scand J Infect Dis; 2006; 38(10):853-9. PubMed ID: 17008228
[TBL] [Abstract][Full Text] [Related]
37. Bactericidal activity of ciprofloxacin upon Escherichia coli and Acinetobacter baumanni.
Zemelman R; Vejar C; Bello H; Domínguez M; González G
Rev Latinoam Microbiol; 1992; 34(4):245-8. PubMed ID: 1345113
[TBL] [Abstract][Full Text] [Related]
38. Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.
Montero A; Ariza J; Corbella X; Doménech A; Cabellos C; Ayats J; Tubau F; Borraz C; Gudiol F
J Antimicrob Chemother; 2004 Dec; 54(6):1085-91. PubMed ID: 15546972
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.
Baran G; Erbay A; Bodur H; Ongürü P; Akinci E; Balaban N; Cevik MA
Int J Infect Dis; 2008 Jan; 12(1):16-21. PubMed ID: 17513154
[TBL] [Abstract][Full Text] [Related]
40. Fatal Acinetobacter baumannii infection with discordant carbapenem susceptibility.
Lesho E; Wortmann G; Moran K; Craft D
Clin Infect Dis; 2005 Sep; 41(5):758-9. PubMed ID: 16080102
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
